Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors
By M. Ieda, Ji-Dong Fu, P. Delgado-Olguín, V. Vedantham, Y. Hayashi, B. Bruneau, Deepak Srivastava. Cell, 2010
2,435 citations recorded by the source corpus.
SUMMARY The reprogramming of fibroblasts to induced pluripotent stem (iPS) cells raises the possibility that a somatic cell could be reprogrammed to an alternative differentiated fate without first becoming a stem/progenitor cell. A large pool of fibroblasts exists in the post-natal heart, yet no single “master regulator” of direct cardiac reprogramming has been identified. Here, we report that a combination of three developmental transcription factors (i.e., Gata4, Mef2c and Tbx5) rapidly and efficiently reprogrammed post-natal cardiac or dermal fibroblasts directly into differentiated cardiomyocyte-like cells. Induced cardiomyocytes expressed cardiac-specific markers, had a global gene expression profile similar to cardiomyocytes, and contracted spontaneously. Fibroblasts transplanted into mouse hearts one day after transduction of the three factors also differentiated into cardiomyocyte-like cells. These findings demonstrate that functional cardiomyocytes can be directly reprogrammed from differentiated somatic cells by defined factors. Reprogramming of endogenous or explanted fibroblasts might provide a source of cardiomyocytes for regenerative approaches.
Subfields: Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/696ab3d5fb53db1cf35407788786fae5041482a5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- K. Hochedlinger
- Richard A. Young
- M. Stadtfeld
- S. Yamanaka
- R. Jaenisch
- Chaomei Chen
- J. Hanna
- Tong Ihn Lee
In Surgery
- Chaomei Chen
- Tong Ihn Lee
- G. Keller
- Richard A. Young
- Meen Chul Kim
- Rachael Dubin
- S. Yamanaka
- H. Ruskoaho
Citations in the corpus
- Induced pluripotent stem cells: past, present, and future. (2012, background): “…iPSCs can be used to recapitulate phenotypes of not only monogenic diseases but also late-onset polygenic diseases, such as Parkinson’s disease (Devine et al., 2011), Alzheimer’s disease (Israel et al., 2012; Yagi et al., 2011; Yahata et al., 2011), and schizophrenia (Brennand et al., 2011).”
- Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage (2012, neutral): “These insights will be valuable to develop improved cardiac reprogramming strategies (Ieda et al., 2010; Qian et al., 2012; Song et al., 2012; Takeuchi and Bruneau, 2009) and to elucidate how disruption of these diverse regulatory modules contributes to congenital heart disease.”
- Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014) (2014, background): “…113.0 2011 2014 2 Kim et al. (2010) NATURE, V467, P285 [32] 102.8 2011 2014 3 Vierbuchen et al. (2010) NATURE, V463, P1035 [23] 93.7 2011 2014 4 Ieda et al. (2010) CELL, V142, P375 [22] 90.7 2011 2014 5 Lister et al. (2011) NATURE, V471, P68 [46] 90.1 2011 2014 6 Gore et al. (2011) NATURE,…”
- Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration (2011, methodology): “Subsequently, by serially removing factors, only GATA4, myocyte-specific enhancer factor 2C (MEF2C) and T-box 5 (TBX5) were found to be capable of inducing the switch from fibroblast to cardiomyocyt”
- Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease (2012, background): “Recently, it has been reported that FBs can be reprogramed to contracting cardiac-like myocytes cells by expressing developmental transcription factors, MEF2, HAND2, GATA4 and TBX5 [56,57], or by treatment with a combination of miRNAs (miRNAs 1, 133, 208 and 499) [58].”
- Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct Reprogramming (2012, positive): “By serial reduction of the 14 factors, it was found that the optimal combination ofGata4,Mef2c, and Tbx5 resulted in GFP expression in 20% of the cells.”
- Induced pluripotency: history, mechanisms, and applications. (2010, background): “2010); and the conversion of fibroblasts into cardiomyocytes by the cardiac factors Gata4, Mef2c, and Tbx5 (Ieda et al. 2010).”
- Somatic cell reprogramming and transitions between pluripotent states: facts, hypotheses, unresolved issues (2010, positive): “Recently, cardiac fibroblasts were elegantly converted into cardiomyocyte-like cells by the ectopic expression of Gata4, Mef2C, and Tbx5 (Ieda et al., 2010).”